Evidence map›Paper›PMID 32422152›Full record

ArticleThe Journal of infection2020

Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects.

Xian Chen, Yuheng Shan, Yingyu Wen, Jia Sun, Haike Du

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Mechanisms of impaired alveolar fluid clearance.Anatomical record (Hoboken, N.J. : 2007) · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. SARS-CoV-2 Infection and Lung Regeneration.Clinical microbiology reviews · 2022
    Review
  17. Review
  18. Review
  19. Stem cell therapy: A promising treatment for COVID-19.World journal of clinical cases · 2021
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Xian ChenDepartment of Emergency, Characteristic Medical Center of People's Armed Police Force, Tianjin, 300162, P.R. China.
Yuheng ShanDepartment of Neurology, Chinese PLA General Hospital, Beijing, 100853, P.R. China; Department of Neurology, Characteristic Medical Center of People's Armed Police Force, Tianjin, 300162, P.R. China; Medical School of Chinese PLA, Beijing, 100853, P.R. China. Electronic address: 964668032@qq.com.
Yingyu WenDepartment of Renal Medicine, Characteristic Medical Center of People's Armed Police Force, Tianjin, 300162, P.R. China.
Jia SunDepartment of Neurology, Characteristic Medical Center of People's Armed Police Force, Tianjin, 300162, P.R. China.
Haike DuDepartment of Emergency, Characteristic Medical Center of People's Armed Police Force, Tianjin, 300162, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mesenchymal Stem CellsPandemicsAzetidinesBetacoronavirusCoronavirus InfectionsCOVID-19HumansPilot ProjectsPneumonia, ViralPurinesPyrazolesRetrospective StudiesSARS-CoV-2SulfonamidesTreatment OutcomeAzetidinesbaricitinibPurinesPyrazolesSulfonamides

Identifiers

PMID32422152
PMCPMC7227593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.